Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferral of Objective Assessment for Pulmonary Embolism
NCT00381511Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Jan 1999
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label trial of low molecular weight heparin calcium in pulmonary embolism (PE) (2 arms), sponsored by Azienda Ospedaliera Universitaria Policlinico. Primary endpoints: Recurrent Venous Thromboembolism at 3 months, Major Bleeding at 3 months and 1 more. Started Jan 1999; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00381511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381511.